Filing Details
- Accession Number:
- 0001209191-19-043397
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-07-26 17:27:16
- Reporting Period:
- 2019-06-13
- Accepted Time:
- 2019-07-26 17:27:16
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1087294 | Cumberland Pharmaceuticals Inc | CPIX | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1075050 | J A Kazimi | 2525 West End Ave. Suite 950 Nashville TN 37203 | Chairman And Ceo | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-06-13 | 60 | $6.42 | 5,762,542 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-06-14 | 60 | $6.37 | 5,762,602 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-06-17 | 60 | $6.33 | 5,762,662 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-06-18 | 60 | $6.36 | 5,762,722 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-06-19 | 60 | $6.35 | 5,762,782 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-06-20 | 60 | $6.33 | 5,762,842 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-06-21 | 60 | $6.34 | 5,762,902 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-06-24 | 60 | $6.54 | 5,762,962 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-06-25 | 60 | $6.56 | 5,763,022 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-06-26 | 60 | $6.54 | 5,763,082 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-06-27 | 60 | $6.48 | 5,763,142 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-06-28 | 60 | $6.49 | 5,763,202 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-07-01 | 60 | $6.52 | 5,763,262 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-07-02 | 60 | $6.49 | 5,763,322 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-07-03 | 60 | $6.46 | 5,763,382 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-07-05 | 60 | $6.49 | 5,763,442 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-07-08 | 60 | $6.37 | 5,763,502 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-07-09 | 60 | $6.15 | 5,763,562 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-07-10 | 60 | $6.07 | 5,763,622 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-07-11 | 60 | $5.93 | 5,763,682 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-07-12 | 60 | $6.01 | 5,763,742 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-07-15 | 60 | $5.85 | 5,763,802 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-07-16 | 60 | $5.88 | 5,763,862 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-07-17 | 60 | $5.85 | 5,763,922 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-07-18 | 60 | $5.84 | 5,763,982 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-07-19 | 60 | $5.69 | 5,764,042 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-07-22 | 60 | $5.75 | 5,764,102 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-07-24 | 60 | $5.93 | 5,764,162 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct |
Footnotes
- The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019.